Pushing the Boundaries of Science to Advance Human Health

Scientists say gene editing holds the key to curing a host of intractable diseases, including cystic fibrosis, HIV, cancer, and cataracts, to name a few. Policymakers fear that, if this key fell into the wrong hands, it could open a Pandora’s box of dangers such as eugenics and performance enhancements on demand. Two Penn Integrates Knowledge professors who are experts in the field recently discussed these pressing issues with Dan Loney on Wharton Business Radio.

James W. Effron University Professor John Gearhart, who holds appointments in thePerelman School of Medicine (PSOM) and in the School of Veterinary Medicineand has served as director of Penn’s Institute for Regenerative Medicine, discovered how to isolate and propagate the world’s first human pluripotent stem cells in 1998.

Read the full story here.

IRM Associate Director, Nancy Speck, PhD, Presented with 2015 Henry M. Stratton Medal Recognizing Contributions to Basic Hematology Research

The American Society of Hematology (ASH) awarded Nancy Speck, PhD, IRM Associate Director and Cell and Developmental Biology Department Chair at the Perelman School of Medicine at the University of Pennsylvania, the 2015 Henry M. Stratton Medal for Basic Science for her “seminal contributions in the area of hematology research” over the summer.

Dr. Speck accepted her award on Tuesday, December 8 during the 57th ASH Annual Meeting and Exposition in Orlando.

She also co-leads the Hematologic Malignancies Program at Penn’s Abramson Cancer Center and is an investigator at the Abramson Family Cancer Research Institute.

“I’m very grateful to ASH for bestowing this huge honor on me,” Speck said. “However this recognition also belongs to all of the wonderful students and postdocs I’ve had the privilege to work with during my career.”

Read the full story here.

ASH Press Release